Sitravatinib Plus Pembrolizumab in Patients With Advanced Treatment-Naïve PD-L1+ Non-Squamous NSCLC

NCT04925986 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Sponsor decision based on data from other clinical trials

Conditions

Carcinoma, Non-Small-Cell Lung
Lung Diseases
Lung Neoplasms
Metastatic Lung Non-Small Cell Carcinoma
Stage IV Lung Non-Small Cell Cancer AJCC v7
PD-L1 Gene Mutation
Advanced Treatment-Naïve PD-L1
Sitravatinib
Pembrolizumab

Interventions

DRUG: Sitravatinib
DRUG: Pembrolizumab

Sponsor

Sarah Goldberg

Collaborators

[object Object]